[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.149.128. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
This Month in The Archives of Neurology
April 2002

This Month in The Archives of Neurology

Arch Neurol. 2002;59(4):516-517. doi:10.1001/archneur.59.4.516

Moghadasian and colleaguescritically assess the clinical and genetic knowledge of cerebrotendinous xanthomatosis (CTX). It is a rare disease with diverse manifestations, including cataracts, Achilles tendon xanthomas, diarrhea, atherosclerotic vascular disease, and diverse neurologic manifestations that include severe mental retardation. Excess production and consequent accumulation of cholestanol in tissues is an important feature and chenodeoxycholic acid is an effective therapy. Early detection and treatment of CTX significantly reduces the impact of the disease. This review alerts the physician to key diagnostic features.

First Page Preview View Large
First page PDF preview
First page PDF preview
×